Copyright
©2013 Baishideng Publishing Group Co.
World J Cardiol. Mar 26, 2013; 5(3): 42-48
Published online Mar 26, 2013. doi: 10.4330/wjc.v5.i3.42
Published online Mar 26, 2013. doi: 10.4330/wjc.v5.i3.42
Characteristic | Patients in the lowest age tertile | Patients in the middle age tertile | Patients in the highest age tertile | P value1 |
Age, mean ± SD (range), yr | 47.6 ± 6.8 (20.5-55.5) | 59.6 ± 2.4 (55.5-64.2) | 70.9 ± 4.8 (64.3-83.7) | < 0.001 |
Female sex | 29 (22.3) | 36 (27.7) | 43 (33.1) | 0.053 |
Body mass index, mean ± SD, kg/m2 | 26.9 ± 5.1 | 28.0 ± 4.9 | 27.4 ± 3.6 | 0.408 |
Obesity2 | 25 (19.2) | 37 (28.5) | 30 (23.1) | 0.466 |
Systolic BP, mean ± SD, mmHg | 128 ± 19 | 134 ± 19 | 133 ± 20 | 0.017 |
Diastolic BP, mean ± SD, mmHg | 77 ± 12 | 77 ± 11 | 73 ± 11 | 0.007 |
Cardiovascular risk factors | ||||
Hypertension | 58 (44.6) | 85 (65.4) | 95 (73.1) | < 0.001 |
Dyslipidemia | 77 (59.2) | 101 (77.7) | 90 (69.2) | 0.082 |
Current smoker | 47 (36.2) | 30 (23.1) | 16 (12.3) | < 0.001 |
Diabetes | 11 (8.5) | 23 (17.7) | 30 (23.1) | 0.001 |
Positive family history | 47 (36.2) | 48 (36.9) | 51 (39.2) | 0.609 |
Manifest atherosclerosis | ||||
CAD | 78 (60.0) | 101 (77.7) | 112 (86.2) | < 0.001 |
ACS | 35 (26.9) | 32 (24.6) | 33 (25.4) | 0.777 |
Previous stroke | 1 (0.8) | 5 (3.9) | 7 (5.4) | 0.038 |
Peripheral artery disease | 2 (1.5) | 11 (8.5) | 6 (4.6) | 0.250 |
Medication3 | ||||
ACE inhibitor | 29 (22.3) | 46 (35.4) | 52 (40.0) | 0.002 |
Betablocker | 47 (36.2) | 60 (46.2) | 67 (51.5) | 0.013 |
Statin | 36 (27.7) | 57 (43.9) | 62 (47.7) | 0.001 |
Other measurements | ||||
LDL, mean ± SD, mmol/L | 2.8 ± 1.0 | 2.7 ± 1.2 | 2.6 ± 1.0 | 0.263 |
LVEF, mean ± SD, % | 70 ± 11 | 68 ± 13 | 70 ± 12 | 0.875 |
Plaque component | Patients in the lowest age tertile | Patients in the middle age tertile | Patients in the highest age tertile | P value1 | P value2 | ||||||
Male | Female | P value | Male | Female | P value | Male | Female | P value | |||
Non-culprit vessels | |||||||||||
Segments available for analysis | n = 154 | n = 44 | n = 159 | n = 54 | n = 140 | n = 67 | |||||
Plaque burden, % | 37 ± 12 | 30 ± 9 | < 0.001 | 42 ± 11 | 35 ± 12 | < 0.001 | 46 ± 10 | 40 ± 11 | < 0.001 | < 0.001 | < 0.001 |
Fibrous volume, % | 53 ± 12 | 44 ± 20 | < 0.001 | 51 ± 12 | 54 ± 13 | 0.161 | 52 ± 11 | 53 ± 12 | 0.947 | 0.949 | 0.005 |
Fibro-fatty volume, % | 13 ± 11 | 17 ± 19 | 0.966 | 11 ± 9 | 17 ± 15 | 0.053 | 13 ± 9 | 12 ± 10 | 0.365 | 0.992 | 0.060 |
NC volume, % | 18 ± 8 | 15 ± 10 | 0.033 | 21 ± 9 | 16 ± 10 | < 0.001 | 20 ± 8 | 19 ± 9 | 0.646 | 0.13 | 0.017 |
DC volume, % | 17 ± 14 | 24 ± 22 | 0.324 | 17 ± 12 | 13 ± 14 | 0.003 | 15 ± 10 | 16 ± 12 | 0.814 | 0.323 | 0.028 |
Lumen volume, mm3 | 398 ± 182 | 342 ± 115 | 0.053 | 348 ± 133 | 308 ± 130 | 0.057 | 310 ± 133 | 332 ± 127 | 0.267 | < 0.001 | 0.815 |
Culprit vessels | |||||||||||
Segments available for analysis | n = 22 | n = 5 | n = 19 | n = 3 | n = 16 | n = 8 | |||||
Plaque burden, % | 48 ± 6 | 44 ± 18 | 0.376 | 43 ± 11 | 47 ± 14 | 0.578 | 51 ± 9 | 49 ± 8 | 0.724 | 0.523 | 0.449 |
Fibrous volume, % | 57 ± 9 | 58 ± 8 | 0.795 | 51 ± 10 | 67 ± 12 | 0.026 | 44 ± 12 | 57 ± 11 | 0.024 | < 0.001 | 0.727 |
Fibro-fatty volume, % | 13 ± 9 | 13 ± 6 | 0.683 | 9 ± 5 | 8 ± 2 | 0.562 | 7 ± 5 | 11 ± 7 | 0.069 | 0.006 | 0.561 |
NC volume, % | 19 ± 8 | 19 ± 7 | 0.930 | 23 ± 9 | 17 ± 8 | 0.285 | 28 ± 7 | 20 ± 7 | 0.018 | 0.003 | 0.697 |
DC volume, % | 11 ± 8 | 10 ± 8 | 0.851 | 17 ± 8 | 8 ± 7 | 0.113 | 22 ± 12 | 13 ± 12 | 0.040 | 0.001 | 0.655 |
Lumen volume, mm3 | 340 ± 144 | 398 ± 340 | 0.541 | 385 ± 171 | 236 ± 133 | 0.168 | 271 ± 82 | 307 ± 116 | 0.394 | 0.201 | 0.505 |
- Citation: Schoenenberger AW, Urbanek N, Toggweiler S, Stuck AE, Resink TJ, Erne P. Ultrasound-assessed non-culprit and culprit coronary vessels differ by age and gender. World J Cardiol 2013; 5(3): 42-48
- URL: https://www.wjgnet.com/1949-8462/full/v5/i3/42.htm
- DOI: https://dx.doi.org/10.4330/wjc.v5.i3.42